×

Bill Gates-backed Ginkgo Bioworks going public via $15 billion SPAC

Published May 11 2021 at 2:04 PM GMT
Key
Points
  • Ginkgo Bioworks is going public via a merger with former MGM CEO Harry Sloan's SPAC in a deal that values the biotech company at $15 billion.




Trending

Stats

  • Published May 11, 2021 2:04 PM GMT